Rohit Dhall MD , MSPH, CPE

Movement Disorder, Neurodegenerative, Dementia & Geriatrics

Professor and Vice Chair of Neurology, Medical Director of Clinical Trials Innovation Unit, University of Arkansas for Medical Sciences

UAMS Medical Center501 Jack Stephens Drive Jackson T. Stephens Spine and Neuroscience Institute, First FloorLittle Rock, AR 72205
Phone+1 501-686-5838
Fax+1 501-603-1539

Education & Training

University of Alabama Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2007 - 2009
University of Alabama Medical CenterResidency, Neurology, 2004 - 2007
The University of Texas Health Science CenterMSPH, Epidemiology, 2001 - 2007
University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2003 - 2004
All India Institute of Medical SciencesClass of 2000

Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders Start of enrollment: 2017 Nov 14
Completed
Not Applicable
Open-label Trial in Parkinson's Disease (PD) Start of enrollment: 2021 Feb 24
Enrolling by invitation
Phase 3
Roles: Contact
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) Start of enrollment: 2020 Sep 23
COMPLETED
PHASE3
Roles: Contact
Fixed-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2019 Dec 13
COMPLETED
PHASE3
Roles: Contact
Fixed-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2019 Dec 13
COMPLETED
PHASE3
Roles: Contact
Parkinson's Foundation PD GENEration Genetic Registry Start of enrollment: 2020 Dec 20
Recruiting
Roles: Principal Investigator, Contact
A Study of TAK-341 in Treatment of Multiple System Atrophy Start of enrollment: 2022 Nov 09
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Principal Investigator
Development of the Virtual Unified Huntington's Disease Rating Scale Start of enrollment: 2022 Sep 22
Completed
Roles: Contact
Join now to see all

PubMed

2 citations
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement.
Michiko K Bruno, Rohit Dhall, Antoine Duquette, Ihtsham U Haq, Lawrence S Honig
Neurology. Clinical Practice. 2024-12-01
1 citations
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Releas...
C Warren Olanow, Robert A Hauser, Daniel J Burdick, Rohit Dhall, Joy Antonelle de Marcaida
Movement Disorders. 2024-02-01
1 citations
Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.
Alberto J Espay, Robert A Hauser, Rohit Dhall, Sandeep Thakkar, Leslie Cloud
Movement Disorders. 2024-02-01

Huntington’s Disease Symposium Details Resources, Seeks Study ParticipantsJanuary 20th, 2023
After Deep Brain Stimulation Surgery, Arkansas Writer’s Tremors Resume … Until Doctor Activates His ImplantsOctober 11th, 2021
Utility of Objective Gait Measures in Levodopa‐Unresponsive Freezing in Parkinson'sJanuary 13th, 2021
Join now to see all